-The Telegraph Reclaimed from Maoists, the natural reserves of Saranda are up against unscrupulous adversaries. At least four mining firms have been extracting iron ore and manganese against their sanctioned capacities in this West Singhbhum region since 2008 right under the nose of the mines department and Jharkhand State Pollution Control Board (JSPCB). The startling fact came to light this January after the two laggard state offices replied to separate RTI petitions filed...

-The Telegraph   The New York Times has reported that Wal-Mart, the US-based retail giant, hushed up an internal investigation sometime after the company was told of a bribery campaign to obtain licences and facilitate rapid expansion in Mexico. Some of the alleged instances of bribery are certain to ring a bell in India where it is not too difficult to bend rules for a price. The New York Times said its “examination...

-IANS CHENNAI: Upset with the Tamil Nadu government for going back on its assurances, the People's Movement Against Nuclear Energy (PMANE) on Monday announced that it would resume an indefinite hunger strike from May 1 against the two 1,000 MW plants at Kudankulam.  "We have decided to go on hunger protest once again from May 1 onwards as the state government has gone against its assurances given to us. A large number...

How an image-fixated chief minister has bent the state’s media to his will If you haven’t heard of an income tax raid on the residential premises of Nitish Kumar’s close aide and treasurer of the ruling Janata Dal-United (JD-U), Vinay Kumar Sinha, you are not alone. Thanks to the local media, it took a while even in Patna—where the house is located—for people to get to know. This, incidentally, is the...

India is coming under increasing pressure from the U.S. and the European Union for the strict patentability criteria it applies for medicines. AS was only to be expected, the two landmark decisions made by the Indian patent office in recent times concerning pharmaceutical patent cases have not gone down well with the multinational drug industry. First, there was the rejection in 2006 of the patent application by the Swiss multinational...